Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are humans adapted to the world they have developed?

Physiology & behavior·2026
Same author

Potential effects of low calcium intake on body composition, muscle function, and appetite.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2026
Same author

About Unsuccessful Responders to Diet and Physical Activity Interventions: A Focus on Energy Balance and Body-Weight Loss.

Nutrients·2026
Same author

Variation in cycling exercise mechanical efficiency in the HERITAGE Family Study.

Physiological reports·2025
Same author

Cardiorespiratory Fitness in Low Calcium Consumers: Potential Impact of Calcium Intake on Cardiorespiratory Fitness.

Nutrients·2025
Same author

Initial and evolutionary profile of adverse responders to an intensive weight loss intervention: the RESOLVE Study.

The Journal of sports medicine and physical fitness·2025

Related Experiment Video

Updated: Jun 2, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Obesity risks: towards an emerging Inuit pattern.

Marie-Ludivine Chateau-Degat1, Eric Dewailly, Guylaine Charbonneau

  • 1School of Dietetics and Human Nutrition and Centre for Indigenous Peoples' Nutrition and Environment (CINE), McGill University, Ste-Anne-de-Bellevue, Canada. marie-ludivine.chateau-degat@crchul.ulaval.ca

International Journal of Circumpolar Health
|April 29, 2011
PubMed
Summary

Obesity rates are high in the Inuit population, particularly among women, with significant links to type 2 diabetes and cardiovascular disease risk factors. Abdominal obesity is a key concern requiring further study.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Related Experiment Videos

Last Updated: Jun 2, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Area of Science:

  • Public Health
  • Anthropometry
  • Epidemiology

Background:

  • Limited research exists on anthropometric measurements and their association with type 2 diabetes and cardiovascular disease (CVD) risk factors in the Inuit population.
  • Understanding these relationships is crucial for targeted health interventions.

Purpose of the Study:

  • To analyze anthropometric measurements and their correlations with type 2 diabetes and CVD risk factors in Inuit individuals.
  • To assess obesity prevalence using various anthropometric indicators within this population.

Main Methods:

  • A cross-sectional study involving 867 Inuit participants (≥18 years) from Nunavik.
  • Collection of anthropometric and biological data.
  • Analysis of obesity prevalence using Body Mass Index (BMI), Waist Circumference (WC), and Body Fat Percentage (%BF).

Main Results:

  • High obesity prevalence was observed: 25.1% (men) and 31.3% (women) by BMI; 20.2% (men) and 55.3% (women) by WC; 22.4% (men) and 22.5% (women) by %BF.
  • All risk factors were significantly associated with anthropometric measures, with increased risk factor prevalence across higher BMI and WC quartiles.
  • Among individuals with abdominal obesity (WC cutoff), 22% had metabolic syndrome and 64.8% were insulin resistant.

Conclusions:

  • Inuit populations exhibit high obesity rates, with a pronounced prevalence of abdominal obesity among women.
  • These findings underscore the need for longitudinal research to fully understand the impact of central and global obesity in Inuit communities.